Validant, a leading transatlantic quality, compliance, and regulatory consulting group, has acquired Oriel STAT A MATRIX (‘Oriel’), a global consultancy and training firm for the medical device industry.
Headquartered in New Jersey, Oriel provides regulatory, quality, and compliance consulting as well as training for the medical device industry. Oriel is an industry leader in quality, compliance, and auditor training for the medical device industry, with the largest library of content in the market and relationships with 90% of the top 10 medical device companies globally. The business leverages a combination of in-person and virtual training courses, ensuring customers have access to knowledge whenever and wherever needed, delivered by industry-leading instructors.
Validant’s acquisition of Oriel is another important step in its international growth strategy, focused on combining best-in-class regulatory and quality providers, and continuing their aggressive growth with further investment. It follows the acquisitions of DataRevive in 2019, a regulatory strategy and consultancy for global clients, and IDEC in 2020, a regulatory consultancy based in Tokyo.
The acquisition will expand the Validant Group’s proposition into training services as well as adding further depth in regulatory consulting with the integration of an experienced team. The combination will also provide customers with increased access to industry-leading consultants and solutions across the product lifecycle.
Commenting on the announcement, Brian Burns, President of Validant said: “It is my pleasure to announce the acquisition of Oriel STAT A MATRIX. Under the leadership of Alan Marash and Judith Glaser Marash, Oriel has developed into a leading training provider for medical device customers. We are delighted to be adding this high-quality team and complementary training services to the Validant Group’s combined proposition as we cement our position as the leading quality, compliance, and regulatory consulting firm in the life science sector globally.”
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Alan Marash, CEO of Oriel, said: “With complimentary services and shared experience within the medical device industry, we’re delighted to be partnering with Validant on the next stage of Oriel’s growth journey. I look forward to working with Chad Hedlund who has promoted to President of Oriel STAT A MATRIX and the Validant team to increase the support that we can provide to our clients across the full suite of regulatory, compliance, and training services, as well as the potential to expand our geographic footprint into new markets.”
Fairmount Partners provided investment banking and advisory services, Bailey & Glasser provided legal advice and Bruce Gendelman Insurance provided insurance advice to the shareholders of Oriel STAT A MATRIX.
OMM provided legal advice, RSM Global provided financial and accounting advice, Deloitte provided tax advice, and Atlantic Global Risk Corporation provided insurance advice to Validant.
Source: Biospace
